Markets
Moderna In Warsaw
Moderna logo seen in Warsaw, Poland, on April 9, 2025 (Jakub Porzycki/Getty Images)

Moderna rises after FDA grants limited approval for next-gen Covid vaccine

Moderna CEO Stéphane Bancel said on Thursday that narrowing the eligibility while focusing on high-risk individuals could actually lead to more immunizations.

J. Edward Moreno

Moderna rose about 4% in early trading after the Food and Drug Administration granted limited approval for its new COVID-19 vaccine.

The FDA approved Modernas second-generation vaccine for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease, the company announced on Saturday. Its first vaccine was previously approved for all people age 12 and older.

This is the latest sign that the Department of Health and Human Services, under the leadership of Robert F. Kennedy Jr., is aiming to curb the prevalence of immunizations. The FDA has signaled it would narrow eligibility for Modernas first vaccine and HHS canceled funding to the company to develop a bird flu vaccine last week.

Moderna, which still makes most of its revenue from Covid vaccines, is down more than 36% so far this year, but investors have reacted positively to the FDAs stance on the shots so far. Moderna CEO Stéphane Bancel said on Thursday that narrowing the eligibility while focusing on high-risk individuals could actually lead to more immunizations.

According to the FDAs estimates, the elderly and high-risk population is 100 million Americans, compared to the 40 million who were vaccinated in the 2024-25 season.

If this administration is going to really try to push vaccination for people at high risk, Im in because this is potentially a larger market than some of the confusion we have seen in the past and some of the skepticism that we have seen in the past, Bancel said at the Bernstein Strategic Decisions Conference.

More Markets

See all Markets
markets

Delta reports better than expected Q1 earnings, surges as oil plummets

Delta Air Lines reported its first-quarter results before markets opened on Wednesday. The carrier’s shares surged 12% in premarket trading.

Delta, which as of today will charge passengers $10 more per checked bag, reported:

  • Adjusted earnings of $0.64 per share, compared to $0.58 per share expected by analysts polled by FactSet.

  • Sales of $14.2 billion, compared to estimates of $14 billion.

Looking ahead, Delta said it expects Q2 earnings per share of between $1 and $1.50, below Wall Street estimates of $1.56 per share — which might be enough to disappoint investors if oil, one of the largest inputs for an airlines' fuel cost base, wasn't tanking. Indeed, West Texas Intermediate crude futures are down more than 16% on Wednesday morning, following President Trump’s comments that he agreed to a two-week ceasefire with Iran on Tuesday evening. Delta did not give any full-year earnings guidance in its press release.

Like other carriers, Delta has taken a hit in recent weeks as oil — and jet fuel — spikes amid the war in Iran. Significant delays, cancellations, and rebookings have also battered US airlines.

markets

Levi Strauss jumps after raising full-year guidance, reporting earnings beat

Levi Strauss rose more than 11% in premarket trading after it beat earnings expectations and raised its full-year guidance.

For its fiscal year 2026, which ends December 1st, the apparel giant now expects to report:

  • Revenue growth between 5.5% to 6.5%, up from 5% to 6%. Analysts polled by FactSet are penciling in about 6.21% sales growth.

  • Adjusted earnings per share between $1.42 to $1.48, up from $1.40 to $1.46, but still a hair below the $1.49 the Street was expecting.

The company also beat expectations for its first quarter, which ended March 1. It reported:

  • Quarterly adjusted earnings per share of $0.42, versus $0.37 expected.

  • Revenue of $1.74 billion, more than 5% ahead of the $1.65 billion that was expected, with direct-to-consumer sales making up the majority of its revenue stream for the quarter.

The stock is up nearly 11% as of 6:35 a.m. ET, having shed roughly ~5% from the start of the year to yesterday's close.

markets

Oil plummets on two-week ceasefire announcement, dragging energy stocks lower

Oil prices are sharply lower Wednesday morning, extending their biggest single-day drop in six years after President Trump announced a two-week ceasefire with Iran that includes reopening the Strait of Hormuz, through which about a fifth of global oil supply flows.

As of 5:10 a.m. ET, international benchmark Brent crude was down 13.6% at around $94 per barrel, while US WTI crude fell ~16% to $95 per barrel — following its steepest one-day decline since the Russia-Saudi price war in March 2020 and extending the overnight selloff.

A slew of energy stocks are also giving back some of their war-driven gains, with oil-and-gas producers including Occidental Petroleum, Devon Energy, Diamondback Energy, ConocoPhillips, APA Corporation, Coterra Energy, and EOG Resources all down 6-9% in premarket trading.

Oil majors Exxon and Chevron both fell more than 5%, while fuel refiners including Marathon Petroleum, Valero, and Phillips 66 moved 4-6% lower.

Oilfield services names like Halliburton and natural gas producer EQT Corp fell 4-5%, while Chemical makers Dow, Inc. and LyondellBasell, along with fertilizer company CF Industries, are also trading lower. Natural gas exporter Cheniere Energy was also deeply in the red.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.